SF3B1 and myelodysplastic syndrome: Several studies have identified mutations in SF3B1 in subsets of solid tumors, as well as in myelodysplastic syndrome and chronic lymphocytic leukemia (CLL), in which they occurred in almost 15% of the reported cases [18, 22].